Schellekens AFA - Search Results

1

Successful treatment of severe, treatment resistant GHB withdrawal through thiopental-coma.

Vos CF, Pop-Purceleanu M, van den Berg MJW, Schellekens AFA. Vos CF, et al. Among authors: schellekens afa. Subst Abus. 2021;42(1):33-38. doi: 10.1080/08897077.2020.1827124. Epub 2020 Oct 12. Subst Abus. 2021. PMID: 33044905 Free article.

2

Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.

Kamal RM, Schellekens A, De Jong CA, Dijkstra BA. Kamal RM, et al. BMC Psychiatry. 2015 Apr 28;15:91. doi: 10.1186/s12888-015-0471-4. BMC Psychiatry. 2015. PMID: 25927622 Free PMC article. Clinical Trial.

3

Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.

Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BA, Schellekens A. Kamal RM, et al. CNS Drugs. 2017 Jan;31(1):51-64. doi: 10.1007/s40263-016-0402-z. CNS Drugs. 2017. PMID: 28004314 Review.

4

Core addiction medicine competencies for doctors: An international consultation on training.

Ayu AP, El-Guebaly N, Schellekens A, De Jong C, Welle-Strand G, Small W, Wood E, Cullen W, Klimas J. Ayu AP, et al. Subst Abus. 2017 Oct-Dec;38(4):483-487. doi: 10.1080/08897077.2017.1355868. Epub 2017 Jul 18. Subst Abus. 2017. PMID: 28718723 Free PMC article.

5

Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.

Beurmanjer H, Kamal RM, de Jong CAJ, Dijkstra BAG, Schellekens AFA. Beurmanjer H, et al. Among authors: schellekens afa. CNS Drugs. 2018 May;32(5):437-442. doi: 10.1007/s40263-018-0516-6. CNS Drugs. 2018. PMID: 29651711 Free PMC article. Clinical Trial.

6

Delayed complications after severe clozapine intoxication: a case report. The pharmacokinetic profile of clozapine and it's important role in the course of symptoms.

van Helvoort M, van Eijndhoven P, Schellekens A, Pop-Purceleanu M, Kramers C, Batalla A. van Helvoort M, et al. Int Clin Psychopharmacol. 2019 Sep;34(5):269-272. doi: 10.1097/YIC.0000000000000272. Int Clin Psychopharmacol. 2019. PMID: 31107832

7

Improving medical students' attitude toward patients with substance use problems through addiction medicine education.

Ayu AP, van der Ven M, Suryani E, Puspadewi N, Joewana S, Rukmini E, de Jong C, Schellekens A. Ayu AP, et al. Subst Abus. 2022;43(1):47-55. doi: 10.1080/08897077.2020.1732512. Epub 2020 Feb 27. Subst Abus. 2022. PMID: 32105582 Clinical Trial.

8

Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.

Beurmanjer H, Luykx JJ, De Wilde B, van Rompaey K, Buwalda VJA, De Jong CAJ, Dijkstra BAG, Schellekens AFA. Beurmanjer H, et al. Among authors: schellekens afa. CNS Drugs. 2020 Jun;34(6):651-659. doi: 10.1007/s40263-020-00730-8. CNS Drugs. 2020. PMID: 32319006 Free PMC article.

9

Unity in diversity: A systematic review on the GHB using population.

Dijkstra BAG, Beurmanjer H, Goudriaan AE, Schellekens AFA, Joosten EAG. Dijkstra BAG, et al. Among authors: schellekens afa. Int J Drug Policy. 2021 Aug;94:103230. doi: 10.1016/j.drugpo.2021.103230. Epub 2021 Apr 20. Int J Drug Policy. 2021. PMID: 33892279 Free article. Review.

10

Characterization of the GHB Withdrawal Syndrome.

Wolf CJH, Beurmanjer H, Dijkstra BAG, Geerlings AC, Spoelder M, Homberg JR, Schellekens AFA. Wolf CJH, et al. Among authors: schellekens afa. J Clin Med. 2021 May 26;10(11):2333. doi: 10.3390/jcm10112333. J Clin Med. 2021. PMID: 34073640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters